AusDoc is expanding beyond its core doctor audience to include primary care nurses through a strategic partnership with the Australian Primary Health Nurse Association (APNA).
From Product to Pathway: What ADHD Care in General Practice Really Needs from Pharma
ADHD is no longer peripheral to Australian general practice. Rising patient demand, prolonged specialist wait times, and growing public awareness mean GPs are now central to ongoing ADHD care. For pharmaceutical companies, this creates a clear opportunity, but also exposes the limits of traditional engagement models.
How AusDoc Drove a 98% Lift in First-Choice for GP Referrals
A national hearing healthcare provider partnered with AusDoc to strengthen GP referral preference for their brand, resulting in a 98% uplift in first-choice GP referral rates
Rebuilding Trust: The Strategic Imperative Pharma can no Longer Ignore
Doctors were clear that pharma delivers substantial scientific progress but equally clear that trust hasn’t kept pace. Addressing this gap between high innovation and low trust is exactly where the opportunity lies to reset the doctor–pharma relationship.
WEBINAR: The Uncomfortable Truth by AusDoc – Will the Doctor See You Now?
Missed the webinar? You can still hear the full and uncensored debrief of what over 1,000 Australian doctors revealed in the AusDoc Big Doctor Survey From Australia’s #1 platform for doctors, AusDoc. Download the webinar recording and slides.
NEXT 2025 Summit – The Uncomfortable Truth by AusDoc – Will the Doctor See You Now?
NEXT Pharma Summit Australia is coming to Sydney on October 22–23, 2025 Australia’s #1 platform for doctors, AusDoc brings the voice of the doctor into the conversation, shaping the future of pharma and healthcare in Australia. Use promo code 'ausdoc' for 10% earlybird discount.
Bridging Gaps in Menopause Care: A Strategic Opportunity for Pharma
Our latest GP survey reveals clear patterns in how Australian doctors are managing menopause with some therapies dominating and others barely used. The findings highlight important opportunities for pharma to support doctors’ decision-making and improve patient care.
Why pharma companies need to invest in educating GPs about rare medical diseases
Most Australian GPs encounter rare disease patients without the knowledge or tools to act quickly. AusDoc survey data reveals exactly where the confidence gaps are — and why pharma has a significant and largely untapped opportunity to step in with targeted GP education.
AusDoc continues to be the first choice for GPs
AusDoc has been confirmed as the #1 medical publication for Australian GPs in the 2025 annual readership survey — ranked first across print, digital and newsletters. The results reinforce AusDoc's unmatched reach for any pharma or health brand looking to engage Australian doctors.
Australian Doctor shortlisted for the prestigious Publication of the Year at the 2025 Mumbrella Publish Awards
Australian Doctor has been shortlisted for one of the most prestigious accolades in the publishing industry — Publication of the Year — at the 2025 Mumbrella Publish Awards.
AusDoc Joins the Conversation at NEXT 25 Australia
NEXT Pharma Summit Australia is coming to Sydney on October 22–23, 2025 Australia’s #1 platform for doctors, AusDoc brings the voice of the doctor into the conversation, shaping the future of pharma and healthcare in Australia. Use promo code 'ausdoc' for 10% earlybird discount.
The Digital Dilemma: Why Experienced Doctors Remain Sceptical of Health Tech
While digital health solutions promise to revolutionise healthcare, not all doctors are convinced. An AusDoc study examining doctors’ views on technology adoption found that those with the most medical experience remain cautious, voicing concerns about security, accuracy, and over-reliance on technology.